+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Multiplex Assay Market Size, Share & Industry Trends Analysis Report By Product, By Type, By End user, By Application (Research & Development, Clinical Diagnostics & Others), By Country and Growth Forecast, 2021-2027

  • PDF Icon

    Report

  • 109 Pages
  • February 2022
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5571182
The Europe Multiplex Assay Market is expected to witness market growth of 9.3% CAGR during the forecast period (2021-2027).

Multiplex assays are used in a variety of domains of life science, including functional genomics, to detect multiple types of biomolecules, including proteins and DNA, at the same time. Unlike traditional assays, multiplex methods need only a single assay to run at a time intending to avoid the risk of subtle variations while running multiple assays simultaneously.

Numerous companies are utilizing a number of combination therapies in order to effectively diagnose multiple diseases and disorders. Various experiments are going on to assess combinations of numerous drugs to discover new treatment for chronic diseases. Hence growing utilization of multiplex assays is expected to rise the popularity of this treatment method across healthcare sector.

According to the data shared by the World Health Organization, an estimate of 4.6 million cases of cancer are being recorded each year across this region. Additionally, cancer is the cause of nearly 2.1 million deaths in this region. Lung cancer is registered as the type of cancer causing 20% of overall cancer deaths. Since these assays are widely used in the diagnosis of cancer and therefore, the multiplex assays market is anticipated to flourish across this region.

The Germany market dominated the Europe Multiplex Assay Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $288.5 million by 2027. The UK market is expected to exhibit a CAGR of 8.5% during (2021 - 2027). Additionally, The France market is anticipated to grow a CAGR of 10.1% during (2021 - 2027).

Based on Product, the market is segmented into Reagents & Consumables, Instruments & Accessories, and Software & Services. Based on Type, the market is segmented into Protein Based Multiplex Assays, Nucleic Acid-Based Multiplex Assay, and Others. Based on End user, the market is segmented into Pharmaceutical & Biotechnology Companies, Research Institutes, Clinical Laboratories, and Hospitals. Based on Application, the market is segmented into Research & Development, Clinical Diagnostics, and Companion Diagnostics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Seegene, Inc., Randox Laboratories Limited, Illumina, Inc., Qiagen N.V., DiaSorin S.p.A. (Luminex Corporation), Abcam plc, and Meso Scale Diagnostics LLC.

Scope of the Study


Market Segments Covered in the Report:


By Product
  • Reagents & Consumables
  • Instruments & Accessories
  • Software & Services

By Type
  • Protein Based Multiplex Assays
  • Nucleic Acid-Based Multiplex Assay
  • Others

By End User
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Clinical Laboratories
  • Hospitals

By Application
  • Research & Development
  • Clinical Diagnostics
  • Companion Diagnostics

By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players


List of Companies Profiled in the Report:


  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • Seegene, Inc.
  • Randox Laboratories Limited
  • Illumina, Inc.
  • Qiagen N.V.
  • DiaSorin S.p.A. (Luminex Corporation)
  • Abcam plc
  • Meso Scale Diagnostics LLC

Unique Offerings from the Publisher


  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Multiplex Assay Market, by Product
1.4.2 Europe Multiplex Assay Market, by Type
1.4.3 Europe Multiplex Assay Market, by End User
1.4.4 Europe Multiplex Assay Market, by Application
1.4.5 Europe Multiplex Assay Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals and Trials
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, May – 2021, Oct) Leading Players
Chapter 4. Europe Multiplex Assay Market by Product
4.1 Europe Reagents & Consumables Market by Country
4.2 Europe Instruments & Accessories Market by Country
4.3 Europe Software & Services Market by Country
Chapter 5. Europe Multiplex Assay Market by Type
5.1 Europe Protein Based Multiplex Assays Market by Country
5.2 Europe Nucleic Acid-Based Multiplex Assay Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Multiplex Assay Market by End User
6.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
6.2 Europe Research Institutes Market by Country
6.3 Europe Clinical Laboratories Market by Country
6.4 Europe Hospitals Market by Country
Chapter 7. Europe Multiplex Assay Market by Application
7.1 Europe Research & Development Market by Country
7.2 Europe Clinical Diagnostics Market by Country
7.3 Europe Companion Diagnostics Market by Country
Chapter 8. Europe Multiplex Assay Market by Country
8.1 Germany Multiplex Assay Market
8.1.1 Germany Multiplex Assay Market by Product
8.1.2 Germany Multiplex Assay Market by Type
8.1.3 Germany Multiplex Assay Market by End User
8.1.4 Germany Multiplex Assay Market by Application
8.2 UK Multiplex Assay Market
8.2.1 UK Multiplex Assay Market by Product
8.2.2 UK Multiplex Assay Market by Type
8.2.3 UK Multiplex Assay Market by End User
8.2.4 UK Multiplex Assay Market by Application
8.3 France Multiplex Assay Market
8.3.1 France Multiplex Assay Market by Product
8.3.2 France Multiplex Assay Market by Type
8.3.3 France Multiplex Assay Market by End User
8.3.4 France Multiplex Assay Market by Application
8.4 Russia Multiplex Assay Market
8.4.1 Russia Multiplex Assay Market by Product
8.4.2 Russia Multiplex Assay Market by Type
8.4.3 Russia Multiplex Assay Market by End User
8.4.4 Russia Multiplex Assay Market by Application
8.5 Spain Multiplex Assay Market
8.5.1 Spain Multiplex Assay Market by Product
8.5.2 Spain Multiplex Assay Market by Type
8.5.3 Spain Multiplex Assay Market by End User
8.5.4 Spain Multiplex Assay Market by Application
8.6 Italy Multiplex Assay Market
8.6.1 Italy Multiplex Assay Market by Product
8.6.2 Italy Multiplex Assay Market by Type
8.6.3 Italy Multiplex Assay Market by End User
8.6.4 Italy Multiplex Assay Market by Application
8.7 Rest of Europe Multiplex Assay Market
8.7.1 Rest of Europe Multiplex Assay Market by Product
8.7.2 Rest of Europe Multiplex Assay Market by Type
8.7.3 Rest of Europe Multiplex Assay Market by End User
8.7.4 Rest of Europe Multiplex Assay Market by Application
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.6 SWOT Analysis
9.2 Bio-Rad laboratories, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Approvals and Trials:
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.4 Seegene, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 Recent strategies and developments:
9.4.4.1 Approvals and Trials:
9.4.4.2 Geographical Expansions:
9.5 Randox Laboratories Limited
9.5.1 Company Overview
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.7 Qiagen N.V.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.8 DiaSorin S.p.A. (Luminex Corporation)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Approvals and Trials:
9.9 Abcam plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expense
9.10. Meso Scale Diagnostics LLC
9.10.1 Company Overview

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • Seegene, Inc.
  • Randox Laboratories Limited
  • Illumina, Inc.
  • Qiagen N.V.
  • DiaSorin S.p.A. (Luminex Corporation)
  • Abcam plc
  • Meso Scale Diagnostics LLC

Methodology

Loading
LOADING...